Balance Sheet ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:01 12/09/2024 am IST			5-day change	1st Jan Change
252.92 ^USD	+0.02%		+3.34%	+47.03%

11/09	ResMed Insider Sold Shares Worth $3,646,950, According to a Recent SEC Filing	MT
06/09	Resmed Insider Sold Shares Worth $479,800, According to a Recent SEC Filing	MT

030523be93caa6ce.j4WMPya6b8PPWRz6RKCpvVzVcPXiJxskcxx8crnX5Jo._LP-cx_fCK2KPHidcPaa6CS6FKPRHmFpHllLKpSwoPfkwM9lFvwst4EfKA

Published financial data: RESMED, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2020	2021	2022	2023	2024
Revenues	2.96B	3.2B	3.58B	4.22B	4.69B
Total Revenues	2.96B	3.2B	3.58B	4.22B	4.69B
Cost of Goods Sold, Total	1.19B	1.31B	1.51B	1.84B	2B
Gross Profit	1.77B	1.89B	2.06B	2.39B	2.69B
Selling General & Admin Expenses, Total	677M	670M	739M	874M	917M
R&D Expenses	202M	225M	254M	288M	308M
Amortization of Goodwill and Intangible Assets - (IS)	79.7M	76.2M	70.73M	72.42M	79.48M
Other Operating Expenses, Total	958M	972M	1.06B	1.23B	1.3B
Operating Income	809M	918M	1B	1.15B	1.38B
Interest Expense, Total	-40.38M	-23.99M	-22.31M	-47.38M	-49.72M
Interest And Investment Income	1.02M	362K	-	-	-
Net Interest Expenses	-39.36M	-23.63M	-22.31M	-47.38M	-49.72M
Income (Loss) On Equity Invest.	-25.06M	-11.2M	-8.49M	-7.26M	-1.85M
Currency Exchange Gains (Loss)	1.33M	-753K	-	-4.2M	-139K
Other Non Operating Income (Expenses)	1.03M	1.05M	3.2M	-1.51M	655K
EBT, Excl. Unusual Items	747M	883M	973M	1.09B	1.33B
Restructuring Charges	-	-13.9M	-	-9.18M	-64.23M
Merger & Related Restructuring Charges	-	-	-	-10.95M	-
Gain (Loss) On Sale Of Investments	-14.52M	14.52M	-12.2M	9.92M	-4.04M
Insurance Settlements	-	-	-	20.23M	-
Legal Settlements	600K	-	-	-	-
EBT, Incl. Unusual Items	733M	884M	960M	1.1B	1.26B
Income Tax Expense	111M	409M	181M	204M	244M
Earnings From Continuing Operations	622M	475M	779M	898M	1.02B
Net Income to Company	622M	475M	779M	898M	1.02B
Net Income - (IS)	622M	475M	779M	898M	1.02B
Net Income to Common Incl Extra Items	622M	475M	779M	898M	1.02B
Net Income to Common Excl. Extra Items	622M	475M	779M	898M	1.02B
Per Share Items
Net EPS - Basic	4.31	3.27	5.34	6.12	6.94
Basic EPS - Continuing Operations	4.31	3.27	5.34	6.12	6.94
Basic Weighted Average Shares Outstanding	144M	145M	146M	147M	147M
Net EPS - Diluted	4.27	3.24	5.3	6.09	6.92
Diluted EPS - Continuing Operations	4.27	3.24	5.3	6.09	6.92
Diluted Weighted Average Shares Outstanding	146M	146M	147M	147M	148M
Normalized Basic EPS	3.23	3.8	4.16	4.65	5.67
Normalized Diluted EPS	3.21	3.77	4.13	4.63	5.65
Dividend Per Share	1.56	1.59	1.68	1.76	1.92
Payout Ratio	36.21	47.78	31.48	28.78	27.65
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	923M	1.03B	1.12B	1.29B	1.53B
EBITA	848M	948M	1.04B	1.2B	1.44B
EBIT	809M	918M	1B	1.15B	1.38B
EBITDAR	949M	1.06B	1.16B	1.33B	1.57B
Total Revenues (As Reported)	2.96B	3.2B	3.58B	4.22B	4.69B
Effective Tax Rate - (Ratio)	15.2	46.3	18.85	18.53	19.28
Current Domestic Taxes	16.69M	-106M	15.08M	50.77M	74.35M
Current Foreign Taxes	125M	532M	178M	199M	219M
Total Current Taxes	141M	426M	193M	250M	294M
Deferred Domestic Taxes	-16.34M	-27M	-15.38M	-24.11M	-27.55M
Deferred Foreign Taxes	-13.54M	10.41M	3.57M	-21.32M	-22.33M
Total Deferred Taxes	-29.88M	-16.59M	-11.82M	-45.43M	-49.88M
Normalized Net Income	467M	552M	608M	682M	833M
Interest on Long-Term Debt	40.38M	23.99M	-	47.38M	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	202M	225M	254M	288M	308M
Net Rental Expense, Total	26.5M	35.5M	35.3M	33.6M	40.8M
Imputed Operating Lease Interest Expense	6.66M	6.51M	7.36M	10.2M	13.23M
Imputed Operating Lease Depreciation	19.84M	28.99M	27.94M	23.4M	27.57M
Stock-Based Comp., COGS (Total)	3.7M	4.15M	5.22M	6.46M	7.56M
Stock-Based Comp., R&D Exp. (Total)	6.59M	8.05M	9.25M	11.63M	14.47M
Stock-Based Comp., SG&A Exp. (Total)	47.26M	51.73M	50.79M	53.05M	58.15M
Total Stock-Based Compensation	57.56M	63.93M	65.26M	71.14M	80.18M

Fiscal Period: June	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	463M	295M	274M	228M	238M
Short Term Investments	-	29.08M	-	12.42M	-
Total Cash And Short Term Investments	463M	324M	274M	240M	238M
Accounts Receivable, Total	484M	625M	602M	736M	837M
Total Receivables	484M	625M	602M	736M	837M
Inventory	417M	457M	851M	1.14B	994M
Prepaid Expenses	159M	95.77M	205M	248M	288M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	-	72.41M	-	2.13M	-
Total Current Assets	1.52B	1.57B	1.93B	2.37B	2.36B
Gross Property Plant And Equipment	1.11B	1.21B	1.26B	1.33B	1.43B
Accumulated Depreciation	-578M	-622M	-633M	-668M	-727M
Net Property Plant And Equipment	536M	592M	630M	666M	699M
Long-term Investments	44.14M	40.16M	49.21M	134M	139M
Goodwill	1.89B	1.93B	1.94B	2.77B	2.84B
Other Intangibles, Total	448M	393M	346M	552M	486M
Accounts Receivable Long-Term	6.96M	6.21M	8.84M	10.08M	18.45M
Deferred Tax Assets Long-Term	41.06M	79.9M	79.75M	133M	204M
Other Long-Term Assets, Total	97.58M	115M	114M	118M	126M
Total Assets	4.59B	4.73B	5.1B	6.75B	6.87B
Liabilities
Accounts Payable, Total	136M	138M	159M	151M	238M
Accrued Expenses, Total	239M	290M	319M	328M	338M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	11.99M	12M	9.92M	9.9M	9.9M
Current Portion of Leases	21.26M	23.58M	21.86M	21.92M	25.28M
Current Income Taxes Payable	64.76M	308M	44.89M	72.22M	108M
Unearned Revenue Current, Total	98.62M	110M	109M	138M	153M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	31.71M	30.2M	25.89M	37.18M	39.79M
Total Current Liabilities	603M	912M	689M	759M	911M
Long-Term Debt	1.16B	643M	765M	1.43B	697M
Long-Term Leases	102M	115M	120M	117M	141M
Unearned Revenue Non Current	87.31M	91.5M	95.46M	119M	137M
Deferred Tax Liability Non Current	13.01M	11.32M	9.71M	90.65M	79.34M
Other Non Current Liabilities	121M	69.74M	54.86M	105M	42.26M
Total Liabilities	2.09B	1.84B	1.74B	2.62B	2.01B
Common Stock, Total	580K	583K	586K	588K	588K
Additional Paid In Capital	1.57B	1.62B	1.68B	1.77B	1.9B
Retained Earnings	2.83B	3.08B	3.61B	4.25B	4.99B
Treasury Stock	-1.62B	-1.62B	-1.62B	-1.62B	-1.77B
Comprehensive Income and Other	-284M	-193M	-313M	-273M	-252M
Total Common Equity	2.5B	2.89B	3.36B	4.13B	4.86B
Total Equity	2.5B	2.89B	3.36B	4.13B	4.86B
Total Liabilities And Equity	4.59B	4.73B	5.1B	6.75B	6.87B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	145M	146M	146M	147M	147M
ECS Total Common Shares Outstanding	145M	146M	146M	147M	147M
Book Value / Share	17.23	19.81	22.95	28.08	33.11
Tangible Book Value	159M	565M	1.08B	807M	1.54B
Tangible Book Value Per Share	1.09	3.88	7.37	5.49	10.46
Total Debt	1.3B	794M	918M	1.58B	874M
Net Debt	836M	469M	644M	1.34B	636M
Debt Equivalent Oper. Leases	212M	284M	282M	269M	326M
Equity Method Investments, Total	14.11M	17.15M	9.92M	65.37M	65.46M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	128M	155M	355M	459M	356M
Inventories - Work In Process, Total	2.81M	4.65M	3.08M	3.96M	2.71M
Inventories - Finished Goods, Total	286M	297M	386M	535M	464M
Land - (BS)	51.8M	54.46M	51.86M	52.06M	51.98M
Buildings, Total	228M	239M	230M	231M	231M
Machinery, Total	629M	714M	769M	831M	890M
Full Time Employees	7.77K	7.97K	8.16K	10.14K	9.98K
Accumulated Allowance for Doubtful Accounts (Supple)	28.51M	32.14M	23.26M	23.6M	21.13M

Fiscal Period: June	2020	2021	2022	2023	2024
Net Income	622M	475M	779M	898M	1.02B
Depreciation & Amortization - CF	102M	115M	123M	125M	137M
Amortization of Goodwill and Intangible Assets - (CF)	38.68M	30.87M	35.18M	47.36M	52.04M
Depreciation & Amortization, Total	140M	146M	158M	173M	189M
Amortization of Deferred Charges, Total - (CF)	41.02M	40.23M	35.54M	25.06M	27.45M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	14.52M	-14.52M	12.2M	-9.92M	4.04M
Asset Writedown & Restructuring Costs	-	13.77M	-	9.18M	33.24M
(Income) Loss On Equity Investments - (CF)	25.06M	11.2M	8.49M	10.14M	1.85M
Stock-Based Compensation (CF)	57.56M	63.93M	65.26M	71.14M	80.18M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-7K	-	-	-20.23M	-
Change In Accounts Receivable	54.38M	-129M	19.35M	-107M	-134M
Change In Inventories	-69.88M	-21.95M	-312M	-249M	172M
Change In Accounts Payable	-23.42M	211M	-248M	31.34M	122M
Change in Other Net Operating Assets	-59M	-58.15M	-168M	-138M	-115M
Cash from Operations	802M	737M	351M	693M	1.4B
Capital Expenditure	-95.33M	-103M	-135M	-120M	-99.46M
Cash Acquisitions	-27.91M	-39.07M	-42.78M	-1.01B	-133M
Sale (Purchase) of Intangible assets	-10.61M	-14.11M	-21.2M	-14.33M	-15.4M
Investment in Marketable and Equity Securities, Total	-31.62M	-21.79M	-13.92M	-28.29M	-11.76M
Other Investing Activities, Total	-14.4M	19.22M	-17.18M	15.2M	-9.7M
Cash from Investing	-180M	-158M	-230M	-1.16B	-270M
Long-Term Debt Issued, Total	1.19B	90M	288M	1.07B	105M
Total Debt Issued	1.19B	90M	288M	1.07B	105M
Long-Term Debt Repaid, Total	-1.28B	-612M	-166M	-405M	-835M
Total Debt Repaid	-1.28B	-612M	-166M	-405M	-835M
Issuance of Common Stock	48.18M	37.79M	47.38M	49.14M	53.09M
Repurchase of Common Stock	-46.06M	-50.21M	-52.41M	-30.63M	-159M
Common Dividends Paid	-225M	-227M	-245M	-258M	-282M
Common & Preferred Stock Dividends Paid	-225M	-227M	-245M	-258M	-282M
Other Financing Activities, Total	-302K	-3.5M	-	-2.36M	-1.29M
Cash from Financing	-317M	-765M	-128M	423M	-1.12B
Foreign Exchange Rate Adjustments	10.92M	18.5M	-14.43M	-2.15M	-1.72M
Net Change in Cash	316M	-168M	-21.57M	-45.82M	10.47M
Supplemental Items
Cash Interest Paid	40.38M	23.99M	22.31M	47.38M	45.71M
Cash Income Tax Paid (Refund)	180M	221M	478M	217M	278M
Levered Free Cash Flow	577M	809M	117M	415M	1.18B
Unlevered Free Cash Flow	602M	824M	131M	445M	1.22B
Change In Net Working Capital	36.55M	-117M	597M	410M	-169M
Net Debt Issued / Repaid	-94.01M	-522M	122M	665M	-730M

Fiscal Period: June	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.63	12.31	12.73	12.15	12.7
Return on Total Capital	14.17	15.34	15.71	14.42	15.11
Return On Equity %	27.21	17.63	24.96	23.96	22.7
Return on Common Equity	27.21	17.63	24.96	23.96	22.7
Margin Analysis
Gross Profit Margin %	59.77	59.1	57.68	56.5	57.38
SG&A Margin	22.88	20.97	20.66	20.7	19.57
EBITDA Margin %	31.21	32.19	31.42	30.6	32.73
EBITA Margin %	28.67	29.67	28.94	28.4	30.65
EBIT Margin %	27.36	28.7	27.96	27.28	29.54
Income From Continuing Operations Margin %	21.02	14.84	21.78	21.25	21.79
Net Income Margin %	21.02	14.84	21.78	21.25	21.79
Net Avail. For Common Margin %	21.02	14.84	21.78	21.25	21.79
Normalized Net Income Margin	15.79	17.26	16.99	16.16	17.78
Levered Free Cash Flow Margin	19.51	25.29	3.28	9.84	25.29
Unlevered Free Cash Flow Margin	20.36	25.76	3.67	10.54	25.95
Asset Turnover
Asset Turnover	0.68	0.69	0.73	0.71